The Centers for Medicare & Medicaid Services yesterday implemented several new infection control actions to combat COVID-19 in nursing homes. One action addresses the inconsistent rate of nursing home inspections mandated by CMS on March 4, which currently range from 11% to 100% across the states.

State survey agencies that fail to inspect all nursing homes by July 31 will be required to submit a corrective action plan or have their federal funds under the Coronavirus Aid, Relief, and Economic Security Act redistributed to compliant states.

Another action expands penalties for nursing home deficiencies, which range from directed plans of correction to civil monetary penalties, with more significant actions for nursing homes with a history of past deficiencies or that cause actual harm or immediate jeopardy to residents.

 

The agency also is deploying additional technical assistance resources to nursing homes, which will focus on the approximately 3,000 low-performing nursing homes with a history of infection control challenges. 

Related News Articles

Headline
Health care providers who received approval to submit a late report on how they used Provider Relief Fund payments received from July 1 to Dec. 31, 2020, must…
Headline
Hospitals are contending with an exhausted workforce, backlogs of care deferred by the pandemic, cracks in the supply chain and a tsunami of financial…
Headline
In a study examining electronic health records for adults who visited an inpatient or outpatient facility between March 2020 and November 2021, COVID-19…
Headline
The Centers for Disease Control and Prevention today released updated guidance for clinicians treating COVID-19 in patients who received the Pfizer COVID-19…
Headline
Pfizer’s COVID-19 vaccine booster for children under age 5 was 80.3% effective and well tolerated in a clinical trial involving 1,678 children who received the…
Headline
The Centers for Disease Control and Prevention yesterday recommended children age 5-11 receive a booster dose five months after completing the Pfizer COVID-19…